Empathetic and persistent communication is key when it comes to talking to parents who are reluctant to vaccinate their child ...

The Global Cancer Vaccines Market is experiencing a significant growth phase, with its valuation rising from $4,188 million in 2019 to an expected $7,303 million by 2027. This rep ...

Univercells Technologies, a Donaldson Life Sciences business and global provider of bioprocessing solutions, announced the ...

Filoviruses are among the globe's most lethal—indeed, so dangerous they can be handled only in high-security laboratories. Yet, more than five decades after the discovery of the Marburg virus and ...

Univercells Technologies has launched the scale-X nitro controller, the latest addition to its scale-X fixed-bed bioreactor ...

Strategic insight into the Liver Cancer Treatment Market reveals a high-growth opportunity, especially in Asia-Pacific, driven by a rising patient po ...

Optibumin® 25 – a 25% recombinant human serum albumin (rHSA ... in 100 mL single-use bags and is suitable for integration into viral vector manufacturing, stem cell preservation, vaccine formulation, ...

Provides ReciBioPharm's customers with access to NewBiologix's Xcell-Eng-HEK293 cell lines for advanced therapies <l ...

We discuss inactivated vaccines, virally and bacterially vectored vaccines, recombinant protein and ... Inactivated virus, viral vector, bacterial vector, subunit and DNA vaccines encoding several ...